{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:42:27Z","timestamp":1794847347723,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Joint Funds for the Innovation of Science and Technology Program of Fujian Province","award":["2018Y9110"],"award-info":[{"award-number":["2018Y9110"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2020J011126"],"award-info":[{"award-number":["2020J011126"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021T140468"],"award-info":[{"award-number":["2021T140468"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Military Med Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Stemness and chemoresistance contribute to cervical cancer recurrence and metastasis. In the current study, we determined the relevant players and role of\n                      <jats:italic>N<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>6<\/jats:italic>\n                      <\/jats:sup>\n                      -methyladenine (m\n                      <jats:sup>6<\/jats:sup>\n                      A) RNA methylation in cervical cancer progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The roles of m\n                      <jats:sup>6<\/jats:sup>\n                      A RNA methylation and centromere protein K (CENPK) in cervical cancer were analyzed using bioinformatics analysis. Methylated RNA immunoprecipitation was adopted to detect m\n                      <jats:sup>6<\/jats:sup>\n                      A modification of\n                      <jats:italic>CENPK<\/jats:italic>\n                      mRNA. Human cervical cancer clinical samples, cell lines, and xenografts were used for analyzing gene expression and function. Immunofluorescence staining and the tumorsphere formation, clonogenic, MTT, and EdU assays were performed to determine cell stemness, chemoresistance, migration, invasion, and proliferation in HeLa and SiHa cells, respectively. Western blot analysis, co-immunoprecipitation, chromatin immunoprecipitation, and luciferase reporter, cycloheximide chase, and cell fractionation assays were performed to elucidate the underlying mechanism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Bioinformatics analysis of public cancer datasets revealed firm links between m\n                      <jats:sup>6<\/jats:sup>\n                      A modification patterns and cervical cancer prognosis, especially through ZC3H13-mediated m\n                      <jats:sup>6<\/jats:sup>\n                      A modification of\n                      <jats:italic>CENPK<\/jats:italic>\n                      mRNA. CENPK expression was elevated in cervical cancer, associated with cancer recurrence, and independently predicts poor patient prognosis [hazard ratio\u2009=\u20091.413, 95% confidence interval\u2009=\u20091.078\u2009\u2212\u20091.853,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012]. Silencing of\n                      <jats:italic>CENPK<\/jats:italic>\n                      prolonged the overall survival time of cervical cancer-bearing mice and improved the response of cervical cancer tumors to chemotherapy in vivo (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). We also showed that CENPK was directly bound to SOX6 and disrupted the interactions of CENPK with \u03b2-catenin, which promoted \u03b2-catenin expression and nuclear translocation, facilitated p53 ubiquitination, and led to activation of Wnt\/\u03b2-catenin signaling, but suppression of the p53 pathway. This dysregulation ultimately enhanced the tumorigenic pathways required for cell stemness, DNA damage repair pathways necessary for cisplatin\/carboplatin resistance, epithelial-mesenchymal transition involved in metastasis, and DNA replication that drove tumor cell proliferation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CENPK was shown to have an oncogenic role in cervical cancer and can thus serve as a prognostic indicator and novel target for cervical cancer treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40779-022-00378-z","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T20:04:00Z","timestamp":1649880240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance"],"prefix":"10.1016","volume":"9","author":[{"given":"Xian","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Ben","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-8595","authenticated-orcid":false,"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"issue":"3","key":"378_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"378_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"378_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/stem.3157","volume":"38","author":"Y He","year":"2020","unstructured":"He Y, Xiao M, Fu H, Chen L, Qi L, Liu D, et al. cPLA2\u03b1 reversibly regulates different subsets of cancer stem cells transformation in cervical cancer. Stem Cells. 2020;38(4):487\u2013503.","journal-title":"Stem Cells"},{"key":"378_CR4","doi-asserted-by":"publisher","first-page":"650383","DOI":"10.3389\/fonc.2021.650383","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang H, Luo Q, Kang J, Wei Q, Yang Y, Yang D, et al. YTHDF1 aggravates the progression of cervical cancer through m6A-Mediated up-regulation of RANBP2. Front Oncol. 2021;11:650383.","journal-title":"Front Oncol."},{"issue":"1","key":"378_CR5","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1038\/s41467-020-16306-5","volume":"11","author":"Z Li","year":"2020","unstructured":"Li Z, Peng Y, Li J, Chen Z, Chen F, Tu J, et al. N6-methyladenosine regulates glycolysis of cancer cells through PDK4. Nat Commun. 2020;11(1):2578.","journal-title":"Nat Commun"},{"issue":"10","key":"378_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41419-020-03071-y","volume":"11","author":"Q Wang","year":"2020","unstructured":"Wang Q, Guo X, Li L, Gao Z, Su X, Ji M, et al. N6-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1\/HK2 modification. Cell Death Dis. 2020;11(10):911.","journal-title":"Cell Death Dis"},{"key":"378_CR7","doi-asserted-by":"publisher","first-page":"650023","DOI":"10.3389\/fcell.2021.650023","volume":"9","author":"H Zhao","year":"2021","unstructured":"Zhao H, Xu Y, Xie Y, Zhang L, Gao M, Li S, et al. m6A regulators is differently expressed and correlated with immune response of esophageal cancer. Front Cell Dev Biol. 2021;9:650023.","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"378_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-020-00872-8","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shi Y, Shen H, Xie W. m6A-binding proteins: the emerging crucial performers in epigenetics. J Hematol Oncol. 2020;13(1):35.","journal-title":"J Hematol Oncol"},{"key":"378_CR9","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.7717\/peerj.1386","volume":"3","author":"YC Lee","year":"2015","unstructured":"Lee YC, Huang CC, Lin DY, Chang WC, Lee KH. Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance. PeerJ. 2015;3:e1386.","journal-title":"PeerJ."},{"issue":"2","key":"378_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3892\/ijo.2012.1744","volume":"42","author":"M Komatsu","year":"2013","unstructured":"Komatsu M, Yoshimaru T, Matsuo T, Kiyotani K, Miyoshi Y, Tanahashi T, et al. Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis. Int J Oncol. 2013;42(2):478\u2013506.","journal-title":"Int J Oncol"},{"issue":"43","key":"378_CR11","doi-asserted-by":"publisher","first-page":"73994","DOI":"10.18632\/oncotarget.18172","volume":"8","author":"H Wang","year":"2017","unstructured":"Wang H, Liu W, Liu L, Wu C, Wu W, Zheng J, et al. Overexpression of centromere protein K (CENP-K) gene in hepatocellular carcinoma promote cell proliferation by activating AKT\/TP53 signal pathway. Oncotarget. 2017;8(43):73994\u20134005.","journal-title":"Oncotarget"},{"issue":"6","key":"378_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1089\/cmb.2019.0237","volume":"27","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xiong S, Liu S, Chen J, Yang H, Liu G, et al. Analysis of gene expression in bladder cancer: possible involvement of mitosis and complement and coagulation cascades signaling pathway. J Comput Biol. 2020;27(6):987\u201398.","journal-title":"J Comput Biol"},{"issue":"35","key":"378_CR13","doi-asserted-by":"publisher","first-page":"38257","DOI":"10.18632\/oncotarget.5499","volume":"6","author":"Y Liu","year":"2015","unstructured":"Liu Y, Hu H, Zhang C, Wang H, Zhang W, Wang Z, et al. Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas. Oncotarget. 2015;6(35):38257\u201369.","journal-title":"Oncotarget"},{"issue":"1","key":"378_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12935-021-01760-y","volume":"21","author":"J Ma","year":"2021","unstructured":"Ma J, Chen X, Lin M, Wang Z, Wu Y, Li J. Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma. Cancer Cell Int. 2021;21(1):65.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"378_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/ncb1396","volume":"8","author":"M Okada","year":"2006","unstructured":"Okada M, Cheeseman IM, Hori T, Okawa K, McLeod IX, Yates JRR, et al. The CENP-H-I complex is required for the efficient incorporation of newly synthesized CENP-A into centromeres. Nat Cell Biol. 2006;8(5):446\u201357.","journal-title":"Nat Cell Biol."},{"issue":"1","key":"378_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymthe.2019.08.015","volume":"28","author":"Y Zou","year":"2020","unstructured":"Zou Y, Lin X, Bu J, Lin Z, Chen Y, Qiu Y, et al. Timeless-stimulated miR-5188-FOXO1\/\u03b2-catenin-c-Jun feedback loop promotes stemness via ubiquitination of \u03b2-catenin in breast cancer. Mol Ther. 2020;28(1):313\u201327.","journal-title":"Mol Ther"},{"issue":"24","key":"378_CR17","first-page":"7364","volume":"62","author":"R Koivusalo","year":"2002","unstructured":"Koivusalo R, Krausz E, Ruotsalainen P, Helenius H, Hietanen S. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand. Cancer Res. 2002;62(24):7364\u201371.","journal-title":"Cancer Res"},{"issue":"19","key":"378_CR18","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.7150\/thno.27806","volume":"8","author":"F Zhou","year":"2018","unstructured":"Zhou F, Yang X, Zhao H, Liu Y, Feng Y, An R, et al. Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer. Theranostics. 2018;8(19):5200\u201312.","journal-title":"Theranostics"},{"key":"378_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12885-015-1016-4","volume":"15","author":"M Segovia-Mendoza","year":"2015","unstructured":"Segovia-Mendoza M, Jurado R, Mir R, Medina LA, Prado-Garcia H, Garcia-Lopez P. Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study. BMC Cancer. 2015;15:21.","journal-title":"BMC Cancer"},{"issue":"8","key":"378_CR20","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","volume":"80","author":"A Mukherjee","year":"2020","unstructured":"Mukherjee A, Chiang CY, Daifotis HA. Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res. 2020;80(8):1748\u201361.","journal-title":"Cancer Res"},{"issue":"25","key":"378_CR21","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.7150\/thno.37717","volume":"9","author":"X Lin","year":"2019","unstructured":"Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y, et al. HBX-induced miR-5188 impairs FOXO1 to stimulate \u03b2-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma. Theranostics. 2019;9(25):7583\u201398.","journal-title":"Theranostics"},{"issue":"1","key":"378_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41392-020-0111-4","volume":"5","author":"X Lin","year":"2020","unstructured":"Lin X, Li AM, Li YH, Luo RC, Zou YJ, Liu YY, et al. Silencing MYH9 blocks HBx-induced GSK3\u03b2 ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma. Signal Transduct Target Ther. 2020;5(1):13.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"378_CR23","first-page":"41","volume":"43","author":"Q Xu","year":"2020","unstructured":"Xu Q, Chen C, Liu B, Lin Y, Zheng P, Zhou D, et al. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways. Oncol Rep. 2020;43(1):41\u201354.","journal-title":"Oncol Rep"},{"issue":"2","key":"378_CR24","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1002\/ctm2.343","volume":"11","author":"X Lin","year":"2021","unstructured":"Lin X, Zheng X, Yang B, Chen J, Xu Q, Wang Q. Clinical significance and immune landscapes of stemness-related and immune gene set-based signature in oral cancer. Clin Transl Med. 2021;11(2):e343.","journal-title":"Clin Transl Med."},{"issue":"1","key":"378_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","volume":"19","author":"B Zhang","year":"2020","unstructured":"Zhang B, Wu Q, Li B, Wang D, Wang L, Zhou YL. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol Cancer. 2020;19(1):53.","journal-title":"Mol Cancer"},{"issue":"4","key":"378_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/sj.neo.7900251","volume":"4","author":"O Kitahara","year":"2002","unstructured":"Kitahara O, Katagiri T, Tsunoda T, Harima Y, Nakamura Y. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia. 2002;4(4):295\u2013303.","journal-title":"Neoplasia"},{"issue":"39","key":"378_CR27","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1038\/s41388-018-0347-4","volume":"37","author":"P Dong","year":"2018","unstructured":"Dong P, Xiong Y, Yu J, Chen L, Tao T, Yi S, et al. Control of PD-L1 expression by miR-140\/142\/340\/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer. Oncogene. 2018;37(39):5257\u201368.","journal-title":"Oncogene"},{"issue":"13","key":"378_CR28","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/onc.2015.234","volume":"35","author":"J Wang","year":"2016","unstructured":"Wang J, Ding S, Duan Z, Xie Q, Zhang T, Zhang X, et al. Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression. Oncogene. 2016;35(13):1692\u2013702.","journal-title":"Oncogene"},{"key":"378_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fcimb.2020.00307","volume":"10","author":"M Budhwani","year":"2020","unstructured":"Budhwani M, Lukowski SW, Porceddu SV, Frazer IH, Chandra J. Dysregulation of stemness pathways in HPV mediated cervical malignant transformation identifies potential oncotherapy targets. Front Cell Infect Microbiol. 2020;10:307.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"378_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ygyno.2017.08.029","volume":"147","author":"SW Lee","year":"2017","unstructured":"Lee SW, Lee SH, Kim J, Kim YS, Yoon MS, Jeong S, et al. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: a multi-institutional retrospective analysis of KROG 16\u201301. Gynecol Oncol. 2017;147(2):334\u20139.","journal-title":"Gynecol Oncol"},{"key":"378_CR31","doi-asserted-by":"publisher","first-page":"100720","DOI":"10.1016\/j.drup.2020.100720","volume":"53","author":"B Li","year":"2020","unstructured":"Li B, Jiang J, Assaraf YG, Xiao H, Chen ZS, Huang C. Surmounting cancer drug resistance: new insights from the perspective of N6-methyladenosine RNA modification. Drug Resist Updat. 2020;53:100720.","journal-title":"Drug Resist Updat."},{"issue":"6","key":"378_CR32","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","volume":"69","author":"J Wen","year":"2018","unstructured":"Wen J, Lv R, Ma H, Shen H, He C, Wang J, et al. Zc3h13 regulates nuclear RNA m6A methylation and mouse embryonic stem cell self-renewal. Mol Cell. 2018;69(6):1028\u201338.","journal-title":"Mol Cell"},{"key":"378_CR33","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fonc.2020.01444","volume":"10","author":"J Pan","year":"2020","unstructured":"Pan J, Xu L, Pan H. Development and validation of an m6A RNA methylation regulator-based signature for prognostic prediction in cervical squamous cell carcinoma. Front Oncol. 2020;10:1444.","journal-title":"Front Oncol"},{"issue":"5\u20136","key":"378_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1101\/gad.309146.117","volume":"32","author":"P Knuckles","year":"2018","unstructured":"Knuckles P, Lence T, Haussmann IU, Jacob D, Kreim N, Carl SH, et al. Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m6A machinery component Wtap\/Fl(2)d. Genes Dev. 2018;32(5\u20136):415\u201329.","journal-title":"Genes Dev"},{"issue":"3","key":"378_CR35","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1111\/jcmm.13470","volume":"22","author":"W Jiang","year":"2018","unstructured":"Jiang W, Yuan Q, Jiang Y, Huang L, Chen C, Hu G, et al. Identification of Sox6 as a regulator of pancreatic cancer development. J Cell Mol Med. 2018;22(3):1864\u201372.","journal-title":"J Cell Mol Med"},{"issue":"Pt 1","key":"378_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2019.07.011","volume":"67","author":"Z Liang","year":"2020","unstructured":"Liang Z, Xu J, Gu C. Novel role of the SRY-related high-mobility-group box D gene in cancer. Semin Cancer Biol. 2020;67(Pt 1):83\u201390.","journal-title":"Semin Cancer Biol"},{"key":"378_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biocel.2019.01.014","volume":"109","author":"M Lin","year":"2019","unstructured":"Lin M, Lei T, Zheng J, Chen S, Du L, Xie H. UBE2S mediates tumor progression via SOX6\/\u03b2-Catenin signaling in endometrial cancer. Int J Biochem Cell Biol. 2019;109:17\u201322.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3\u20134","key":"378_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10495-019-01588-y","volume":"25","author":"Y Chen","year":"2020","unstructured":"Chen Y, Song Y, Mi Y, Jin H, Cao J, Li H, et al. microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6. Apoptosis. 2020;25(3\u20134):205\u201316.","journal-title":"Apoptosis"},{"issue":"10","key":"378_CR39","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/mc.23246","volume":"59","author":"L Chen","year":"2020","unstructured":"Chen L, Xie Y, Ma X, Zhang Y, Li X, Zhang F, et al. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt\/\u03b2-catenin signaling. Mol Carcinog. 2020;59(10):1159\u201373.","journal-title":"Mol Carcinog"},{"issue":"18","key":"378_CR40","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1158\/0008-5472.CAN-17-0704","volume":"77","author":"I Kurtsdotter","year":"2017","unstructured":"Kurtsdotter I, Topcic D, Karl\u00e9n A, Singla B, Hagey DW, Bergsland M, et al. SOX5\/6\/21 prevent oncogene-driven transformation of brain stem cells. Cancer Res. 2017;77(18):4985\u201397.","journal-title":"Cancer Res"},{"issue":"1","key":"378_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41388-019-0983-3","volume":"39","author":"Y He","year":"2020","unstructured":"He Y, Davies CM, Harrington BS, Hellmers L, Sheng Y. CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of \u03b2-catenin and E-cadherin. Oncogene. 2020;39(1):219\u201333.","journal-title":"Oncogene"},{"issue":"5","key":"378_CR42","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41419-020-2519-8","volume":"11","author":"C Hu","year":"2020","unstructured":"Hu C, Zhang M, Moses N, Hu CL, Polin L, Chen W, et al. The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53. Cell Death Dis. 2020;11(5):328.","journal-title":"Cell Death Dis"},{"issue":"2","key":"378_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1124\/mol.119.117978","volume":"97","author":"Z Zhong","year":"2020","unstructured":"Zhong Z, Virshup DM. Wnt signaling and drug resistance in cancer. Mol Pharmacol. 2020;97(2):72\u201389.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"378_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13046-020-1530-3","volume":"39","author":"C Yu","year":"2020","unstructured":"Yu C, Chen F, Wang X, Cai Z, Yang M, Zhong Q, et al. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting. J Exp Clin Cancer Res. 2020;39(1):31.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-022-00378-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40779-022-00378-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-022-00378-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:52:40Z","timestamp":1772830360000},"score":1,"resource":{"primary":{"URL":"https:\/\/mmrjournal.biomedcentral.com\/articles\/10.1186\/s40779-022-00378-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1186\/s40779-022-00378-z","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"assertion":[{"value":"17 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent and ethics approval were obtained from the Ethics Committee of Shanghai Outdo Biotech Corporation (YB M-05\u201302). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. The Institutional Animal Ethical Committee, Experimental Animal Center of Fujian Medical University and Fujian Cancer Hospital approved the protocols for animal studies (K2020-036\u201301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets used and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing\u00a0 interests"}}],"article-number":"19"}}